Borreliosi
Condroprotezione
Artrosi

Artrite Reumatoide

Osteoporosi Maschile



 

 

 


1. Franceschi C, Olivieri F, Colonna-Romano G, et al.
Allele frequencies of +874T->A single nucleotide polymorphism
at the first intron of interferon-gamma gene in a group of Italian
centenarians. Lio D, Scola L, Crivello A, Bonafe M. Exp
Gerontol 2002 Jan 3;37(2-3):315-319.


2. Eckstein F, Lochmuller EM, Lill CA, et al.
Bone strength at clinically relevant sites displays substantial
heterogeneity and is best predicted from site-specific bone
densitometry. J Bone Miner Res 2002 Jan;17(1):162-71.


3. Ringe JD, Rovati LC.
Treatment of osteoporosis in men with fluoride a
lone or in
combination with bisphosphonates. Calcif Tissue Int 2001
Oct;69(4):252-5.


4. Bilezikian JP, Kurland ES.
Therapy of male osteoporosis with parathyroid hormone. Calcif
Tissue Int 2001 Oct;69(4):248-51.


5. Francis RM.
Androgen replacement in aging men. Calcif Tissue Int 2001
Oct;69(4):235-8.


6. Wuster C, Hadji P.
Use of quantitative ultrasound densitometry (QUS) in male
osteoporosis. Calcif Tissue Int 2001 Oct;69(4):225-8.


7. Lombardi A, Ross PD.
The assessment of bone mass in men. Calcif Tissue Int 2001
Oct;69(4):222-4.


8. Audran M, Chappard D, Legrand E, et al.
Bone microarchitecture and bone fragility in men: DXA and
histomorphometry in humans and in the orchidectomized rat
model. Calcif Tissue Int 2001 Oct;69(4):214-7.


9. Chavassieux P, Meunier PJ.
Histomorphometric approach of bone loss in men. Calcif Tissue
Int 2001 Oct;69(4):209-13.
10. Gennari L, Brandi ML.
Genetics of male osteoporosis.Calcif Tissue Int 2001
Oct;69(4):200-4.


11. Johnell O, Kanis J, Gullberg G.
Mortality, morbidity, and assessment of fracture risk in male
osteoporosis. Calcif Tissue Int 2001 Oct;69(4):182-4.


12. Ishikawa A, Ishikawa S, Hirakawa M.
Osteoporosis, bone turnover and hypogonadism in elderly men
with treated leprosy. Lepr Rev 2001 Sep;72(3):322-9.


13. Seeman E.
Unresolved issues in osteoporosis in men. Rev Endocr Metab
Disord 2001 Jan;2(1):45-64.


14. Ringe JD, Faber H, Dorst A.
Alendronate treatment of established primary osteoporosis in men:
results of a 2-year prospective study. J Clin Endocrinol Metab
2001 Nov;86(11):5252-5.


15. Rogucka E, Jankowska EA, Welon Z, et al.
Bone mineral status of Polish men in the course of normal ageing.
Andrologia 2001 Sep;33(5):287-92.


16. Hattori M, Morita N, Tsujino Y, et al.
Vitamins D and K in the treatment of osteoporosis secondary to
graft-versus-host disease following bone-marrow transplantation. J
Int Med Res 2001 Jul-Aug;29(4):381-4.


17. Tangredi JF, Buxton IL.
Hypertension as a complication of topical testosterone therapy.
Ann Pharmacother 2001 Oct;35(10):1205-7.


18. Tsuruoka S, Nishiki K, Sugimoto K, et al.
Chronotherapy with active vitamin D3 in aged stroke-prone
spontaneously hypertensive rats, a model of osteoporosis. Eur J
Pharmacol 2001 Oct 5;428(2):287-93.


19. Javaid MK, McCrudden PR, Taylor P, et al.
Comparison of calcaneal ultrasound and DXA to assess the risk of
corticosteroid-induced osteoporosis: a cross-sectional study.
Osteoporos Int 2001;12(9):788-93.


20. Xu SZ, Zhou W, Mao XD, et al.
Reference data and predictive diagnostic models for calcaneus
bone mineral density measured with single-energy X-ray
absorptiometry in 7428 Chinese. Osteoporos Int
2001;12(9):755-62.


21. Floreani A, Mega A, Tizian L, et al.
Bone metabolism and gonad function in male patients
undergoing liver transplantation: a two-year longitudinal study.
Osteoporos Int 2001;12(9):749-54.


22. Melton LJ 3rd, Orwoll ES, Wasnich RD.
Does bone density predict fractures comparably in men and
women? Osteoporos Int 2001;12(9):707-9.


23. Grossman JM, MacLean CH.
Quality indicators for the management of osteoporosis in
vulnerable elders. Ann Intern Med 2001 Oct 16;135(8 Pt
2):722-30.


24. Wartofsky L.
Update in endocrinology. Ann Intern Med 2001 Oct 16;135(8
Pt 1):601-9.


25. Hindso K, Lauritzen JB.
Osteoporosis and Colles' fracture. Ugeskr Laeger 2001 Oct
1;163(40):5503-6.


26. Seeman E.

Clinical review 137: Sexual dimorphism in skeletal size, density,
and strength. J Clin Endocrinol Metab 2001 Oct;86(10):4576-
84.


27. Lopez-Herce Cid JA, del Castillo Rueda A, Teigell Garcia
L, et al.
Osteoporosis in patients admitted to an internal medicine service
of a university general hospital. An Med Interna 2001
Mar;18(3):121-3.


28. Xue Y, Jia W, Zhang H, et al.
Urinary cross-linked N-telopeptides of type I collagen and bone
metabolic diseases. Chin Med J (Engl) 1999 Feb;112(2):149-52.


29. de Vente W, Post GB, Twisk JW, et al.
Effects of health measurements and health information in youth
and young adulthood in dietary intake-20-y study results from
the Amsterdam Growth and Health Longitudinal Study. Eur J
Clin Nutr 2001 Oct;55(10):819-23.


30. James WH.
The bones and hormones of deep water divers and pilots of high
performance aircraft. Occup Environ Med 2001 Oct;58(10):682.


31. Underwood A. II.
Fitness, nutrition, beauty. More veggies, please. Newsweek 2001
Fall-Winter;138(11A):42-6.


32. Adler J, Raymond J. II.
Fitness, nutrition, beauty. Fighting back, with sweat. Newsweek
2001 Fall-Winter;138(11A):34-41.


33. Monteforte P, Molfetta L, Grillo G, et al.
Disodium clodronate in painful nonresponsive periarthropathy of
the hip. Int J Tissue React 2000;22(4):111-5.


34. Springen K. I.
The body, the brain, hormones. Taming raging hormones.
Newsweek 2001 Fall-Winter;138(11A):30-2.


35. Oefelein MG, Ricchuiti V, Conrad W, et al.
Skeletal fracture associated with androgen suppression induced
osteoporosis: the clinical incidence and risk factors for patients
with prostate cancer. J Urol 2001 Nov;166(5):1724-8.


36. Lopez-Ibarra PJ, Pastor MM, Escobar-Jimenez F, et al.
Bone mineral density at time of clinical diagnosis of adult-onset
type 1 diabetes mellitus. Endocr Pract 2001 Sep-Oct;7(5):346-
51.


37. Lunt M, Masaryk P, Scheidt-Nave C, et al.
The effects of lifestyle, dietary dairy intake and diabetes on bone
density and vertebral deformity prevalence: the EVOS study.
Osteoporos Int 2001;12(8):688-98.

38. Murrell P, Todd CJ, Martin A, et al.
Postal administration compared with nurse-supported
administration of the QUALEFFO-41 in a population
sample: comparison of results and assessment of psychometric
properties. Osteoporos Int 2001;12(8):672-9.


39. Juby AG, Davis P.
A prospective evaluation of the awareness, knowledge, risk
factors and current treatment of osteoporosis in a cohort of
elderly subjects. Osteoporos Int 2001;12(8):617-22.


40. Feuerherm AJ, Borset M, Seidel C, et al.
Elevated levels of osteoprotegerin (OPG) and hepatocyte
growth factor (HGF) in rheumatoid arthritis. Scand J
Rheumatol 2001;30(4):229-34.


41. Keller C, Hafstrom I, Svensson B.
Bone mineral density in women and men with early
rheumatoid arthritis. Scand J Rheumatol 2001;30(4):213-
20.


42. Kobayashi I, Kawamura N, Okano M.
A long-term survivor with the immune dysregulation,
polyendocrinopathy, enteropathy, X-linked syndrome. N Engl
J Med 2001 Sep 27;345(13):999-1000.


43. Dawson-Hughes B.
Bone loss accompanying medical therapies. N Engl J Med
2001 Sep 27;345(13):989-91.


44. Rovetta G, Maggiani G, Molfetta L, et al.
One-month follow-up of patients treated by intravenous
clodronate for acute pain induced by osteoporotic vertebral
fracture. Drugs Exp Clin Res 2001;27(2):77-81.


45. Smith MR, McGovern FJ, Zietman AL, et al.
Pamidronate to prevent bone loss during androgendeprivation
therapy for prostate cancer. N Engl J Med 2001
Sep 27;345(13):948-55.


46. Diamond T, Sambrook P, Williamson M, et al.
Guidelines for treatment of osteoporosis in men. Aust Fam
Physician 2001 Aug;30(8):787-91.


47. Diamond T, Sambrook P, Williamson M, et al.
Men and osteoporosis. Aust Fam Physician 2001
Aug;30(8):781-5.


48. Melton LJ 3rd, Orwoll ES, Wasnich RD.
Does bone density predict fractures comparably in men and
women? Osteoporos Int 2001;12(9):707-9.


49. Ebeling PR, Wark JD, Yeung S, et al.
Effects of calcitriol or calcium on bone mineral density, bone
turnover, and fractures in men with primary osteoporosis: a
two-year randomized, double blind, double placebo study. J
Clin Endocrinol Metab 2001 Sep;86(9):4098-103.


50. Rizzoli R, Schaad MA, Uebelhart B.
Osteoporosis in men. Nurs Clin North Am 2001
Sep;36(3):467-79, ix.


51. Wang L, Banu J, McMahan CA, et al.
Male rodent model of age-related bone loss in men. Bone
2001 Aug;29(2):141-8.


52. Pande I, Francis RM.
Osteoporosis in men. Best Pract Res Clin Rheumatol 2001
Jul;15(3):415-27.


53. Nguyen TV, Maynard LM, Towne B, et al.
Sex differences in bone mass acquisition during growth: the
Fels Longitudinal Study. J Clin Densitom 2001
Summer;4(2):147-57.


54. Weber TJ, Drezner MK.
Effect of alendronate on bone mineral density in male
idiopathic osteoporosis. Metabolism 2001 Aug;50(8):912-5.


55. Legrand E, Hedde C, Gallois Y, et al.
Osteoporosis in men: a potential role for the sex hormone
binding globulin. Bone 2001 Jul;29(1):90-5.


56. Huuskonen J, Vaisanen SB, Kroger H, et al.
Regular physical exercise and bone mineral density: a fouryear
controlled randomized trial in middle-aged men. The
DNASCO study. Osteoporos Int 2001;12(5):349-55.


57. Orwoll E, Ettinger M, Weiss S, et al.
Alendronate for the treatment of osteoporosis in men.
N Engl J Med 2000 Aug 31;343(9):604-10.


58. Rovetta G, Monteforte P, Balestra V.
Intravenous clodronate for acute pain induced by osteoporotic
vertebral fracture. Drugs Exp Clin Res 2000;26(1):25-30.

 

 

 
©2002 webtemplateszone.com     free web templates at webtemplateszone.com